File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Randomised phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma

TitleRandomised phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma
Authors
Issue Date2015
Citation
Annals of Oncology, 2015 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/220165

 

DC FieldValueLanguage
dc.contributor.authorKang, YK-
dc.contributor.authorYau, TCC-
dc.contributor.authorPark, JW-
dc.contributor.authorLim, HY-
dc.contributor.authorLee, TY-
dc.contributor.authorObi, S-
dc.contributor.authorChan, SL-
dc.contributor.authorQin, S-
dc.contributor.authorKim, RD-
dc.contributor.authorCasey, M-
dc.contributor.authorChen, C-
dc.contributor.authorBhattacharyya, H-
dc.contributor.authorWilliams, JA-
dc.contributor.authorValota, O-
dc.contributor.authorChakrabarti, D-
dc.contributor.authorKudo, M-
dc.date.accessioned2015-10-16T06:31:16Z-
dc.date.available2015-10-16T06:31:16Z-
dc.date.issued2015-
dc.identifier.citationAnnals of Oncology, 2015-
dc.identifier.urihttp://hdl.handle.net/10722/220165-
dc.languageeng-
dc.relation.ispartofAnnals of Oncology-
dc.titleRandomised phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.doi10.1093/annonc/mdv388-
dc.identifier.hkuros255616-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats